Connection
Matthew Sikora to Androstenes
This is a "connection" page, showing publications Matthew Sikora has written about Androstenes.
|
|
Connection Strength |
|
 |
|
 |
|
0.135 |
|
|
|
-
Capper CP, Larios JM, Sikora MJ, Johnson MD, Rae JM. The CYP17A1 inhibitor abiraterone exhibits estrogen receptor agonist activity in breast cancer. Breast Cancer Res Treat. 2016 05; 157(1):23-30.
Score: 0.135